Qube Research & Technologies Ltd - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 149 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$61,557
+1227.8%
64,122
+409.6%
0.00%
Q4 2022$4,636
-91.3%
12,582
-89.9%
0.00%
Q3 2022$53,000
-56.2%
124,369
-19.6%
0.00%
-100.0%
Q2 2022$121,000
+116.1%
154,597
+250.3%
0.00%
Q4 2021$56,000
-82.3%
44,132
-47.6%
0.00%
-100.0%
Q2 2021$316,000
+496.2%
84,158
+446.5%
0.00%
+300.0%
Q4 2020$53,000
-75.5%
15,400
-71.0%
0.00%
-66.7%
Q3 2020$216,00053,0220.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
D. E. Shaw & Co., Inc. 8,051,858$6,281,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders